MedPath

Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

Conditions
Abortion, Induced
Registration Number
NCT00206193
Lead Sponsor
Atrium Medical Center
Brief Summary

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Pregnant women by whom a termination of pregnancy is desired.
Exclusion Criteria
  • Women with liver/kidney disease
  • Women on long-term use of corticosteroids (> 6 months)
  • Cardiovascular problems
  • Therapy-resistant diabetic women
  • Therapy-resistant asthma/bronchitis
  • Thalassemia
  • Ulcerative colitis
  • Peptic ulcer disease
  • Glaucoma
  • Porphyria
  • Allergic reaction to prostaglandin or mifepristone
  • Women with a prior caesarian section or women with contractions at the start of the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Atrium Medisch Centrum

🇳🇱

Heerlen, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath